KC Animal Health Blog

<< Return to Blog List

Prommune Selects the Corridor for Global Operations

by Emily McVey | May 13, 2015

The KC Animal Health Corridor is excited to announce that Prommune, an animal vaccine research and development company, will locate its global commercial operations within the Kansas City region.

Prommune will initially operate from temporary office space at 9393 West 110th St., Overland Park, Kansas, and plans to hire approximately six employees within the next three years. The company selected the Corridor due to its unsurpassed logistics, manufacturing and talent pool.

Prommune presented at the 2013 KC Animal Health Investment Forum.

About Prommune, Inc.
Prommune is a research and development company that has created a unique and patented means to safely and effectively awaken the body’s own natural immune defenses without inflammatory side-effects.  Such immune activation is possible through the use of novel immune stimulatory peptides, which are derived from a naturally-occurring protein component of the immune system.  The use of these host-derived immune stimulatory peptides provides a broad therapeutic platform enabling the treatment of normal and antibiotic-resistant infections and the rapid generation a huge variety of new vaccines for human and veterinary medicine. prommuneinc.com

About the KC Animal Health Corridor
Companies with a business location in the KC Animal Health Corridor account for more than half of the sales generated by the global animal health industry. The Corridor, anchored by Manhattan, Kansas, and Columbia, Missouri, is home to more than 300 animal health companies, representing the largest concentration in the world. For more information, visit KCanimalhealth.com.




News Releases

Media Coverage

Inside the Corridor

Investment Forum 2015